Thank you for Subscribing to CIO Applications Weekly Brief
Hyperfine Receives FDA Approval for Deep Learning Portable MRI, Ushering in the Future of Life-Saving Diagnostics
The world's first portable MRI uses deep learning to revolutionize imaging at the patient's bedside, enabling prompt diagnosis and treatment.
Fremont, CA: "Swoop is already a game-changer in terms of its ability to provide MR imaging at a patient's bedside," said Dr. Fady Charbel, Head of the Department of Neurosurgery at the University of Illinois of Chicago. "With the integration of deep learning-based image reconstruction, clinicians can now visualize anatomy and pathology more clearly and with increased confidence enabling diagnosis more expeditiously, critical for the treatment of acute neurological conditions."
Swoop, the world's first FDA-cleared portable MRI machine got developed by Hyperfine, Inc., a pioneering medical equipment business. Hyperfine created a swoop to enable quick diagnosis and treatment for all patients, regardless of money, resources, or geography, stretching the bounds of traditional imaging technologies and increasing patient access to life-saving care. The Swoop Portable MR Imaging System generates high-quality pictures at low magnetic field intensity, allowing physicians to scan, diagnose, and treat patients in various clinical situations. Swoop may be wheeled right to the patient's bedside, plugged into a conventional electrical wall outlet, and operated by an iPad®. Swoop gathers pictures in minutes, offering essential decision-making skills in emergency departments (ED), operating rooms (OR) outside the sterile field, & intensive care units (ICU), among others. It was designed as a supplementary device to traditional MRIs for a fraction of the cost.
Hyperfine has received FDA 510(k) clearance for its innovative, sophisticated picture reconstruction technology that employs deep learning (DL). The improved picture quality as a result of this novel method raises the diagnostic usefulness of portable MRI.
Current MRI systems have limitations because of their size, fixed location, expense, and personnel training needs. Hyperfine has addressed these restrictions by redesigning MRIs from the ground up and using smart computing. Swoop is the result: an easy-to-use, portable, and economical technology that costs less than the yearly service contract of many traditional MRI systems.
"Improved image quality through artificial intelligence, paired with the lower cost and bedside capabilities of Swoop, are enabling greater access to high-quality MR imaging for patients, regardless of income, resources, or location," said Dave Scott, president, and chief executive officer of Hyperfine.
Better picture quality can help physicians make a more accurate and timely diagnosis. Quicker diagnosis and treatment can lead to shorter hospital stays and a better overall healthcare experience for patients. However, a swoop can now offer crisp, clear T1, T2, and FLAIR pictures thanks to the advent of its deep learning-based superior image reconstruction technology. Hyperfine gained FDA approval for its sophisticated artificial intelligence (AI) application in January.